The growing overlap of diabetes, heart disease, and kidney disorders is creating a complex global health challenge, pushing experts to rethink the way chronic diseases are managed.

A new wave of health challenges is emerging worldwide as more people are living with multiple long-term conditions at the same time. Known as cardiometabolic multimorbidity, this condition refers to the presence of interconnected diseases such as type 2 diabetes, cardiovascular disease, and chronic kidney disease in the same individual.

Experts warn that this combination of illnesses is becoming increasingly common across both high-income and low-income countries, creating enormous pressure on healthcare systems. Patients affected by multiple cardiometabolic conditions often require multiple medications, frequent medical visits, and long-term monitoring, leading to higher healthcare costs and increased risk of complications.

The presence of several chronic diseases together is associated with greater illness burden, reduced quality of life, and a higher risk of premature death. However, despite the growing scale of the problem, healthcare systems continue to approach these conditions separately, with different specialists often managing individual diseases in isolation.

This disease-specific approach can result in fragmented care, where the connection between diabetes, heart disease, and kidney problems is not fully addressed. Experts believe that managing these conditions through a more integrated model could improve patient outcomes and reduce the burden on healthcare systems.

A new three-part scientific series has brought together current evidence to highlight the need for a comprehensive response to cardiometabolic multimorbidity. The first paper examines the global patterns and spread of these combined conditions, focusing on their epidemiology and changing trends.

The second paper explores the biological mechanisms behind these interconnected diseases, examining how shared risk factors and underlying processes contribute to their development and progression.

The final paper focuses on management strategies, discussing the need for coordinated care models that move beyond single-disease treatment and address the overall health needs of patients.

Researchers emphasise that cardiometabolic multimorbidity requires a shift in healthcare thinking — from treating individual diseases separately to understanding the complex interactions between multiple conditions.

As populations age and lifestyle-related diseases continue to rise, building integrated healthcare approaches will be essential to prevent complications, improve quality of life, and reduce premature deaths linked to cardiometabolic diseases.

The challenge ahead is clear: healthcare systems must evolve from fragmented disease management towards a patient-centred approach that recognises the interconnected nature of chronic illnesses.